 |
MCR Therapeutics
Last updated: January 18, 2024
Founders Minying Cai and Victor Hruby
Country: USA | Add Funding
MCR Therapeutics developed targeted peptides through their research into drug design and bioactivity expression relating to hormone activity in the brain and periphery. The peptides, which are specific for certain melanocortin receptors, represent a leap forward in novel options for skin cancer prevention, detection and treatment.
MCR Therapeutics developed targeted peptides through their research into drug design and bioactivity expression relating to hormone activity in the brain and periphery. The peptides, which are specific for certain melanocortin receptors, represent a leap forward in novel options for skin cancer prevention, detection and treatment.
